The CDSCO panel approves Exemed Pharmaceuticals to manufacture and market the antidiabetic drug imiglimin HCl SR tablets.

Published Date: 27 Nov 2023

Based in New Delhi on the Phase III clinical trial report and bioequivalency study report of the antidiabetic medication imiglimin hydrochloride presented by.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Remote monitoring can improve recovery from cancer surgery

2.

Intractable cancers may respond better to treatment when using new radiation and high-performance computing.

3.

A Win for AI in Cancer; 2025's Transformative Drugs; FDA Clarifies 'Underway' Trials

4.

Conditional EU Nod for Weekly Pill in Pediatric Glioma

5.

high response rate when using a bispecific antibody to treat R/R multiple myeloma.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot